This MedLibrary.org supplementary page on Overactive bladder syndrome is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:
Related Sponsors
 |
Please help improve this article or section by expanding it. Further information might be found on the talk page or at requests for expansion. (January 2007) |
| ICD-10 | N32.8 |
|---|---|
| ICD-9 | 596.51 |
Overactive bladder (OAB) is a urological condition defined by a set of symptoms: "urgency, with or without urge incontinence, usually with frequency and nocturia." The International Continence Society(ICS) is responsible for this definition. There exists, however, some controversy over the use of this term because these symptoms taken in isolation may overlap with those of other bladder conditions, including interstitial cystitis, or rarely even bladder tumours.
The etiology of OAB is unclear, and indeed there may be multiple possible causes. It is often associated with detrusor overactivity, a pattern of bladder muscle contraction observed during urodynamics, and treatments for OAB, are usually synonymous with treatments for detrusor overactivity. OAB is distinct from stress urinary incontinence, but when they occur together is usually known as mixed incontinence.
Earlier reports estimated that about one in six adults in the United States or Europe had OAB.[1][2] Because the average age of people in the developed world is increasing, it is expected that OAB will become more common in the future as the prevalence of OAB increases with age.[1][2] However, a recent Finnish population-based survey[3] showed that the prevalence had been largely overestimated due to methodological shortcomings regarding age distribution and low participation (in earlier reports). OAB affects approximately half of that proposed earlier.[3]
In 2008 researchers found that simulating the condition in rats caused overactivation of their locus caeruleus, and it is thought this could cause anxiety and disrupted sleep in humans.[4]
Treatment for OAB includes lifestyle modification (fluid restriction, avoidance of caffeine), bladder retraining, antimuscarinic drugs (darifenacin, hyoscyamine, oxybutynin, tolterodine, solifenacin, trospium), and various devices (Urgent PC Neuromodulation System, InterStim). Intravesical botulinum toxin A is also used in some intractable cases, although not with formal FDA approval. The antimuscarinic fesoterodine was recommended for approval by the European Medicines Agency in February 2007, and will become available for use during 2008.
References
- ^ a b "Stewart WF, Van Rooyen JB, Cundiff GW, Abrams P, Herzog AR, Corey R, Hunt TL, Wein AJ. Prevalence and burden of overactive bladder in the United States World Journal of Urology 2003 May;20(6):327-36.".
- ^ a b Milsom I, Abrams P, Cardozo L, Roberts RG, Thuroff J, Wein AJ. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int. 2001 Jun;87(9):760-6.
- ^ a b "Tikkinen KAO, Tammela TLJ, Rissanen AM, Valpas A, Huhtala H, Auvinen A. Is the Prevalence of Overactive Bladder Overestimated? A Population-Based Study in Finland PLoS ONE 2007 2(2):e195.".
- ^ New Scientist, 23 July, 2008, p. 12 [1]
Support Resources
- Incontact.org
- The Continence Foundation
- Cystitis & Overactive Bladder Foundation - UK
- Canada IC & OAB Resource Center
DJ Iron Nox
Information Resources
- Overcoming Overactive Bladder
- Interstitial Cystitis Survival Guide
Wikipedia content modification information:
- This page was last modified on 29 August 2008, at 22:40.
Wikipedia Authorship and Review
Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.
Wikipedia Usage Guidelines
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Overactive bladder syndrome".
The URL for this specific entry is:
All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.